Weili Yan, Ph.D. - Publications

Affiliations: 
2006 University of Kentucky, Lexington, KY 
Area:
Pharmacology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Wei J, Yan W, Li X, Ding Y, Tai HH. Thromboxane receptor alpha mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells. Lung Cancer (Amsterdam, Netherlands). 69: 26-32. PMID 19853959 DOI: 10.1016/J.Lungcan.2009.09.009  0.562
2007 Wei J, Yan W, Li X, Chang WC, Tai HH. Activation of thromboxane receptor alpha induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cells. Biochemical Pharmacology. 74: 787-800. PMID 17632087 DOI: 10.1016/J.Bcp.2007.06.008  0.569
2007 Yan W, Chen W, Huang L. Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines. Molecular Immunology. 44: 3672-81. PMID 17521728 DOI: 10.1016/j.molimm.2007.04.009  0.318
2006 Huang X, Yan W, Gao D, Tong M, Tai HH, Zhan CG. Structural and functional characterization of human microsomal prostaglandin E synthase-1 by computational modeling and site-directed mutagenesis. Bioorganic & Medicinal Chemistry. 14: 3553-62. PMID 16439136 DOI: 10.1016/J.Bmc.2006.01.010  0.464
2006 Yan W, Ding Y, Tai HH. 14-3-3zeta interacts with human thromboxane receptors and is involved in the agonist-induced activation of the extracellular-signal-regulated kinase. Biochemical Pharmacology. 71: 624-33. PMID 16413928 DOI: 10.1016/J.Bcp.2005.11.027  0.575
2006 Yan W, Tai HH. Glycogen synthase kinase-3 phosphorylation, T-cell factor signaling activation, and cell morphology change following stimulation of thromboxane receptor alpha. The Journal of Pharmacology and Experimental Therapeutics. 317: 267-74. PMID 16352701 DOI: 10.1124/jpet.105.096826  0.561
Show low-probability matches.